Inventor

GRIGORIEVA JULIA

US23 patents

⚠️ This page may combine multiple inventors who share the name “GRIGORIEVA JULIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GRIGORIEVA JULIA

BIODESIX INC

Method and system for determining whether a drug will be effective on a patient with a disease

Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Method and system for determining whether a drug will be effective on a patient with a disease

Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway

Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway

Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway

Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Method for predicting breast cancer patient response to combination therapy

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups

Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

ROEDER HEINRICH

Method and system for determining whether a drug will be effective on a patient with a disease

Monitoring treatment of head and neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

RÖDER HEINRICH

Method and system for determining whether a drug will be effective on a patient with a disease

Method and system for determining whether a drug will be effective on a patient with a disease

RÖDER JOANNA

Method for predicting breast cancer patient response to endocrine therapy